SCHEMBL8286107

SCHEMBL8286107

Cc1cc(N2CCN(c3ccccc3)CC2)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.54
MAPT P10636 8/20 0.40
KDM4E B2RXH2 6/20 0.40
HPGD P15428 4/20 0.40
TSHR P16473 3/20 0.40
HSD17B10 Q99714 2/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
CCND2 P30279 1/20 0.40
CCND3 P30281 1/20 0.40
IGF1R P08069 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
MAPK1 P28482 4/20 0.38
GAA P10253 2/20 0.38
GFER P55789 1/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286110 0.94 PDE11A (0.50) PDE11AKDM4EHPGDTSHRHSD17B10
SCHEMBL8287829 0.93 PDE11A (0.64) PDE11AMAPTHPGDTSHRHSD17B10
SCHEMBL8287827 0.93 PDE11A (0.51) PDE11AMAPTKDM4EHPGDHSD17B10
SCHEMBL8287424 0.91 PDE11A (0.48) PDE11AMAPTKDM4ETSHRHSD17B10
SCHEMBL8287828 0.91 PDE11A (0.49) PDE11AKDM4EHPGDHSD17B10CDK4
SCHEMBL8286112 0.90 NCF1 (0.50) PDE11AMAPTKDM4EHPGDCDK4
SCHEMBL8286097 0.87 PDE11A (0.45) PDE11AGFERLMNAPOLB
SCHEMBL8286111 0.87 PDE11A (0.45) PDE11AMAPTKDM4EHPGDTSHR
SCHEMBL8287531 0.86 PDE11A (0.44) PDE11AMAPTMAPK1GAALMNA
SCHEMBL8285163 0.83 POLB (0.50) PDE11AMAPTKDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed